De Laurentiis M, Borstnar S, Campone M, Warner E, et al. Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population. Breast Cancer Res Treat 2021 Oct 8. pii: 10.1007/s10549-021-06374.
PMID: 34625861